Webinar

Strategic Onshoring for Biologics: Enhancing Manufacturing Control and Reliability

Available on-demand

60 Minutes

As global uncertainty grows, biotech and biopharma companies are rethinking manufacturing strategies to reduce risk and ensure continuity. Onshoring drug substance development for biologics offers a powerful way to strengthen control, improve reliability, and accelerate timelines. This webinar will explore the strategic advantages of onshoring, including streamlined regulatory compliance, improved process oversight, and greater flexibility for innovation. Industry experts will share practical insights on planning and executing onshore transitions, technology considerations, and how these efforts can safeguard critical programs. Join us to learn why onshoring is becoming a cornerstone of risk mitigation and long-term success in biologics manufacturing.

Speakers

Pramthesh Patel, Ph.D.

Vice President, Process Development & MSAT

Avid Bioservices

Pramthesh (Prem) Patel, Ph.D. is Vice President of Process Development and Manufacturing Sciences and Technology with over 35 years in the pharmaceutical industry. He began at Bristol Myers Squibb in drug discovery, later joining GSK to lead upstream process development for biologics. Mr. Patel pioneered cell line expression systems, chemically defined media, and intensified fed-batch processes. He has contributed to six approved marketing applications globally and holds a Ph.D. in cellular physiology and molecular biology from the University of Florida